SCOTT ROCKLAGE

Profile

First Name

: SCOTT

Middle Name

:

Last Name

: ROCKLAGE

Related Companies
Titles
Company Name
Related People
DIRECTOR
RENNOVIA INC
JOHN BORKHOLDER, THOMAS BOUSSIE, MICHELLE CHEUNG, SAMUEL COLELLA, GERRIT KLAERNER, ANDREW MCMILLAN, KEVIN MOORE, VINCE MURPHY, ENRICO POLASTRO, KURT SWOGGER, ROBERT WEDINGER, TODD WERPY
DIRECTOR
PULMATRIX INC
ROBERT CLARKE, ROBERT CONNELLY, ROBERT T CONNELLY, ROBERT T. CONNELLY, DAVID EDWARDS, MARK GABRIELSON, STEVEN GILLIS, KURT GRAVES, DAVID HAVA, MICHAEL HIGGINS, DAVID MAKI, TERRANCE MCGUIRE, TERRY MCGUIRE, LAUREN SILVERMAN
EXECUTIVE OFFICER
5AM CO-INVESTORS III, L.P.
JOHN DIEKMAN, ANDREW SCHWAB
DIRECTOR
ACHAOGEN INC
JON B. BRUSS, ALAN B. COLOWICK, TROY COX, JOHN DOYLE, JOHN C. DOYLE, BECKI FILICE, MICHAEL FISCHBACH, IAN R. FRIEDLAND, HALLEY E. GILBERT, KENNETH J. HILLAN, JOHN F. HOLLWAY, DENNIS HOM, J. KEVIN JUDICE, THOMAS KING, KENT LIEGINGER, KENT E. LIEGINGER, GARY LOEB, ROBERT MORE, HEINZ E. MOSER, KENNETH NUSSBACHER, BRYAN ROBERTS, BRYAN E. ROBERTS, CAMILLE SAMUELS, CAMILLE D. SAMUELS, ZERYN SARPANGAL, TOBIN C. SCHILKE, JOHN W. SMITHER, GREGORY STEA, LEE SWEM, CHRISTOPHER WALSH, CHRISTOPHER T. WALSH, CHRISTINE WELCH, BLAKE WISE
DIRECTOR
RELYPSA INC
LANCE BERMAN, JERRY M. BUYSSE, PAUL HASTINGS, RON HUNT, JIM JOHNSON, GERRIT KLAERNER, RONALD KRASNOW, VIJAY LATHI, CLAIRE LOCKEY, JANIS NAEVE, DEEPA PAKIANATHAN, THOMAS SCHUETZ, JAY P. SHEPARD, JONATHAN SILVERSTEIN, WILHELM STAHL, KLAUS VEITINGER
DIRECTOR
WAVERX INC
MARK COLELLA, MARC M. GIBELEY
DIRECTOR
SEMPRUS BIOSCIENCES CORP
SIMEON GEORGE, ROBERT LANGER, CHRISTOPHER LOOSE, DAVID L. LUCCHINO, PURNESH SEEGOPAUL, JOHN SULLIVAN
DIRECTOR
VARIATION BIOTECHNOLOGIES (US), INC.
DAVID E. ANDERSON, JEFF BAXTER, ADAM BUCKLEY, KEVIN FORREST, STEPHEN GILLIS, STEVE GILLIS, STEVEN GILLIS, MARC J. KIRCHMEIER, JEFFREY LEIDEN, EGIDIO NASCIMENTO, MICHAEL STEINMETZ, STEVE VIGNAU, STEVEN VIGNAU
DIRECTOR
KINESTRAL TECHNOLOGIES, INC.
HOWARD S BERGH, HOWARD S. BERGH, HOWARD SAM BERGH, SAM BERGH, SUK-BAE CHA, MINJAI CHO, DONG UK CHOI, SAM COLELLA, JEAN-FRANCOIS HERIS, GEOFFREY RICHARDSON, DIPENDER SALUJA, DOUGLAS SCHENDT, BRUCE SOHN, DAVID SUMMA, HOWARD TURNER, SEUNG-WON YANG, SUENG-WON YANG
DIRECTOR
NOVIRA THERAPEUTICS, INC.
NATHANIEL BROWN, DOUGLAS CARR, OSVALDO FLORES, ANTHONY FORD-HUTCHINSON, DANIEL E. GEFFKEN, GIANNI GROMO, GEORGE HARTMAN, KLAUS KLUMPP, GREGORY KORBEL, SCOTT M. ROCKLAGE, CHRISTIAN S. SCHADE, TIM SHANNON
EXECUTIVE OFFICER
5AM CO-INVESTORS IV, L.P.
JOHN DIEKMAN, ANDREW SCHWAB
DIRECTOR
K2 THERAPEUTICS, INC.
NEIL ABDOLLAHIAN, KEN BARTIZAL, BONNIE BASSLER, PH.D., DAN BURGESS, DANIEL D BURGESS, DANIEL D. BURGESS, CARIN CANALE-THEAKSTON, PAUL DARUWALA, STEVE ELMS, KEVIN FORREST, TIMOTHY R FRANSON, DAVID GOLLAHER, PATRICK HERON, KEVIN JUDICE, NINA KJELLSON, JAMES LEVINE, JAMES MERSON, PH.D., CHRYSA MINEO, JESSICA OIEN, MATTHEW ONAITIS, ROBERT J PEREZ, SCOTT M ROCKLAGE, TAYLOR SANDISON, TAYLOR SANDISON, M.D., TED SCHROEDER, THEODORE R SCHROEDER, THEODORE R. SCHROEDER, PREETAM SHAH, PH.D., RYAN SPENCER, JEFFREY STEIN, JEFFREY STEIN, PH.D., LAURA TADVALKAR, PH.D., LESLIE TARI, PH.D., DIRK THYE, SHANE WARD
DIRECTOR
CIDARA THERAPEUTICS, INC.
NEIL ABDOLLAHIAN, KEN BARTIZAL, BONNIE BASSLER, PH.D., DAN BURGESS, DANIEL D BURGESS, DANIEL D. BURGESS, CARIN CANALE-THEAKSTON, PAUL DARUWALA, STEVE ELMS, KEVIN FORREST, TIMOTHY R FRANSON, DAVID GOLLAHER, PATRICK HERON, KEVIN JUDICE, NINA KJELLSON, JAMES LEVINE, JAMES MERSON, PH.D., CHRYSA MINEO, JESSICA OIEN, MATTHEW ONAITIS, ROBERT J PEREZ, SCOTT M ROCKLAGE, TAYLOR SANDISON, TAYLOR SANDISON, M.D., TED SCHROEDER, THEODORE R SCHROEDER, THEODORE R. SCHROEDER, PREETAM SHAH, PH.D., RYAN SPENCER, JEFFREY STEIN, JEFFREY STEIN, PH.D., LAURA TADVALKAR, PH.D., LESLIE TARI, PH.D., DIRK THYE, SHANE WARD
DIRECTOR
PULMATRIX OPERATING COMPANY, INC.
ROBERT CLARKE, ROBERT CONNELLY, ROBERT T CONNELLY, ROBERT T. CONNELLY, DAVID EDWARDS, MARK GABRIELSON, STEVEN GILLIS, KURT GRAVES, DAVID HAVA, MICHAEL HIGGINS, DAVID MAKI, TERRANCE MCGUIRE, TERRY MCGUIRE, LAUREN SILVERMAN
DIRECTOR
PULMATRIX, INC.
AKIHISA AKAO, HOJABR ALIMI, RICHARD BATYCKY, TODD BAZEMORE, CHRISTOPHER CABELL, ROBERT CLARKE, RICHARD CONLEY, WILLIAM DUKE, GREGORY FRENCH, STEVEN GILLIS, KURT GRAVES, SAMEER HARISH, DAVID HAVA, MICHAEL HIGGINS, MICHAEL J. HIGGINS, MARK IWICKI, PETER LUDLUM, DAVID MAKI, TERRANCE MCGUIRE, AMIT MUNSHI, AMIT D. MUNSHI, . OCULUS INNOVATIVE SCIENCES, INC., TEOFILO RAAD, JAMES ROACH, MATTHEW SHERMAN, MICHELLE S. SIEGERT, ANAND VARADAN
EXECUTIVE OFFICER, DIRECTOR
EXPANSION THERAPEUTICS, INC.
MATTHEW DISNEY, MATTHEW DISNEY, PH.D., KEVIN FORREST, KEVIN FORREST, PH.D., JASON HAFLER, JASON HAFLER, PH.D., YUJIRO HATA, YUJIRO HATA, M.B.A., CAMPBELL MURRAY, M.B.B.S., M.B.A., ANDY PHILLIPS, PH.D., SCOTT ROCKLAGE, PH.D., BETH SEIDENBERG, M.D., RENATO SKERLJ, PH.D., PAUL STONE, LAURA TADVALKAR, PH.D.
EXECUTIVE OFFICER, DIRECTOR
ALBAMUNITY, INC.
DAVID ALLISON, MEREDITH FISHER, ROGER KITTERMAN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-08-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-02 
2018-06-20
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-01-26 
2018-06-20
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-10 
2017-08-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-08-11 
2017-06-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-28 
2017-02-10
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-01 
2016-12-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-28 
2015-10-30
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-02-05 
2015-06-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-13 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-02-17
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-02-10 
2014-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-30 
2014-06-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-30 
2014-02-26
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-25 
2014-02-26
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-09-25 
2014-02-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-30 
2014-02-14
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-27 
2014-02-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-10 
2013-12-09
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-27 
2013-12-04
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2013-12-03 
2013-08-28
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-27 
2013-04-10
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-27 
2013-03-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-06 
2013-03-01
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-27 
2013-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02 
2013-01-02
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-01 
2012-12-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-26 
2012-11-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-10-24 
2012-11-08
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-16 
2012-10-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02 
2012-10-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-26 
2012-08-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-10 
2012-08-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-26 
2012-06-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-06-20 
2012-06-05
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-01 
2012-02-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-12-14 
2011-12-14
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-01 
2011-09-27
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-16 
2011-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02 
2011-08-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-03 
2011-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-06-03 
2011-07-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-11-17 
2011-05-02
D/A
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-25 
2010-12-22
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-09 
2010-09-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-03 
2010-07-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-04-27 
2010-05-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-04-27 
2010-04-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-06 
2010-04-07
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-01 
2010-02-25
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2009-12-01 
2009-12-17
D
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2009-12-01 
2009-11-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-10-16 
2009-09-04
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-25 
2009-06-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-06-19